Game-changing Strategies of European Pharma Companies
Game-changing Strategies of European Pharma Companies
Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory
17-Jan-2017
Europe
Description
Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights on the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalisation of key processes across drug development and manufacturing. It analyzes the dynamics catalyzing growth, profiles organizations presenting significant growth opportunities, and outlines innovative industry trends of key participants who play a vital role in the pharmaceutical landscape.
The research covers the top 5 European pharmaceutical companies, based on their industry position. The companies included in the study are Bayer, AstraZeneca, Roche, Novartis, and Sanofi. These companies are benchmarked across 5 key growth levers, namely core areas of focus, digital footprint, value chain excellence, strategic collaborations and partnerships, and beyond-the-pill services and solutions.
Highlights of the company profiles include:
• Company snapshot
• Performance analysis (market revenue forecast)
• Portfolio analysis
• Key marketed products and patent expiry
• SWOT analysis
• Strategic analysis of growth levers
Table of Contents
Executive Summary
Key Questions this Study will Answer
European Pharma Ecosystem
5 Big Themes for Innovation in European Pharma Companies
T10 European Pharma Companies
Focus on Core Areas
Digital Footprint
Value Chain Excellence
Strategic Collaborations/Alliances or Partnerships
Beyond the Pill Services and Solutions
Bayer Company Snapshot
Company Performance Analysis
Company Portfolio Analysis
Top 10 Marketed Products and Patent Expiries
Company SWOT Analysis
Strategic Analysis of Growth Levers
AstraZeneca Company Snapshot
Company Performance Analysis
Company Portfolio Analysis
Top 10 Marketed Products and Patent Expiries
Company SWOT Analysis
Strategic Analysis of Growth Levers
Novartis Company Snapshot
Company Performance Analysis
Company Portfolio Analysis
Top 10 Marketed Products and Patent Expiries
Company SWOT Analysis
Strategic Analysis of Growth Levers
Roche Company Snapshot
Company Performance Analysis
Company Portfolio Analysis
Top 10 Marketed Products and Patent Expiries
Company SWOT Analysis
Strategic Analysis of Growth Levers
Sanofi Company Snapshot
Company Performance Analysis
Company Portfolio Analysis
Top 10 Marketed Products and Patent Expiries
Company SWOT Analysis
Strategic Analysis of Growth Levers
The Last Word
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Aarti Chitale |
Industries | Healthcare |
WIP Number | 9AB9-00-69-00-00 |
Is Prebook | No |